Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$2.37
-8.1%
$1.70
$0.76
$2.86
$97.51M1.3183,174 shs123,906 shs
Femasys Inc. stock logo
FEMY
Femasys
$0.92
-1.0%
$0.98
$0.69
$1.80
$30.23M-2.56264,298 shs130,675 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.26
+1.8%
$2.43
$1.99
$3.80
$69.24M0.5767,508 shs44,033 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.61
+0.4%
$4.70
$4.01
$9.33
$75.48M1.29190,684 shs36,733 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apyx Medical Corporation stock logo
APYX
Apyx Medical
+12.47%+14.67%+54.49%+196.01%+86.96%
Femasys Inc. stock logo
FEMY
Femasys
-0.50%-3.78%+16.16%-17.03%-16.28%
InspireMD, Inc. stock logo
NSPR
InspireMD
-1.55%-2.20%-11.20%-16.85%-7.11%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-5.56%-3.16%-6.71%+0.44%-14.21%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apyx Medical Corporation stock logo
APYX
Apyx Medical
1.6625 of 5 stars
0.05.00.04.20.01.70.6
Femasys Inc. stock logo
FEMY
Femasys
3.8107 of 5 stars
3.55.00.00.03.82.50.6
InspireMD, Inc. stock logo
NSPR
InspireMD
3.3632 of 5 stars
3.54.00.00.02.72.50.6
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.4661 of 5 stars
3.63.00.00.00.60.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apyx Medical Corporation stock logo
APYX
Apyx Medical
2.67
Moderate BuyN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
3.00
Buy$8.67842.03% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5099.12% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67153.07% Upside

Current Analyst Ratings Breakdown

Latest FEMY, SRTS, NSPR, and APYX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
6/11/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/13/2025
Femasys Inc. stock logo
FEMY
Femasys
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $6.00
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
5/9/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$48.10M1.86N/AN/A$0.38 per share6.24
Femasys Inc. stock logo
FEMY
Femasys
$1.63M18.36N/AN/A$0.10 per share9.20
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M9.85N/AN/A$1.83 per share1.23
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.81$0.43 per share10.63$3.41 per share1.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$23.46M-$0.55N/AN/AN/A-42.37%-156.85%-31.92%8/6/2025 (Estimated)
Femasys Inc. stock logo
FEMY
Femasys
-$18.82M-$0.91N/AN/AN/A-1,242.06%-392.45%-137.15%8/14/2025 (Estimated)
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1046.1020.04N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest FEMY, SRTS, NSPR, and APYX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/8/2025Q1 2025
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$0.13-$0.10+$0.03-$0.10$9.39 million$9.43 million
5/8/2025Q1 2025
Femasys Inc. stock logo
FEMY
Femasys
-$0.17-$0.23-$0.06-$0.23$1.14 million$0.34 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apyx Medical Corporation stock logo
APYX
Apyx Medical
N/AN/AN/AN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apyx Medical Corporation stock logo
APYX
Apyx Medical
3.21
5.45
4.64
Femasys Inc. stock logo
FEMY
Femasys
0.02
0.93
0.54
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
55.33%
Femasys Inc. stock logo
FEMY
Femasys
65.27%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
15.20%
Femasys Inc. stock logo
FEMY
Femasys
11.54%
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Apyx Medical Corporation stock logo
APYX
Apyx Medical
27037.79 million32.05 millionOptionable
Femasys Inc. stock logo
FEMY
Femasys
3032.53 million22.60 millionNot Optionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Apyx Medical stock logo

Apyx Medical NASDAQ:APYX

$2.37 -0.21 (-8.14%)
Closing price 04:00 PM Eastern
Extended Trading
$2.42 +0.05 (+2.11%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Femasys stock logo

Femasys NASDAQ:FEMY

$0.92 -0.01 (-1.00%)
Closing price 04:00 PM Eastern
Extended Trading
$0.93 +0.01 (+0.87%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.26 +0.04 (+1.80%)
Closing price 04:00 PM Eastern
Extended Trading
$2.26 0.00 (0.00%)
As of 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.61 +0.02 (+0.44%)
As of 04:00 PM Eastern

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.